The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,803.00
Bid: 1,801.00
Ask: 1,803.00
Change: 38.00 (2.15%)
Spread: 2.00 (0.111%)
Open: 1,788.00
High: 1,805.00
Low: 1,770.00
Prev. Close: 1,765.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed acquisition of PBM for $85m

20 Aug 2019 07:00

RNS Number : 5528J
IMI PLC
20 August 2019
 

20 August 2019

IMI announces the proposed acquisition of speciality valve manufacturer PBM for $85m

IMI plc ("IMI" or the "Group") announces the proposed acquisition of PBM Inc., ("PBM") for an enterprise value of $85m (£70.3m1). PBM will become part of IMI's Critical Engineering division. In the year to December 2018, PBM generated revenues of $35.6m (£29.4m), adjusted EBITDA of $6.8m (£5.6m) and adjusted EBIT of $6.3m (£5.2m).The proposed acquisition of PBM is fully aligned with IMI's strategy and represents an important opportunity to broaden IMI Critical Engineering's offering into attractive, adjacent markets. Closing is expected to take place within the next two months, subject to normal merger filings.PBM overviewPBM is a manufacturer of high-quality industrial valves and flow control products. The company is based in Irwin, Pennsylvania, USA and end-markets include Pharmaceutical / Biotechnology, Consumer Products and Chemical. In its largest segment Pharma / Bio, PBM enjoys a leading market position in the US. The company is owned by the senior management team who will remain with the business post-acquisition, apart from the retiring Chairman.

Transaction highlights

Ü

The acquisition extends IMI Critical Engineering's market presence into new, growing segments - including Pharmaceutical / Biotechnology - fully in-line with IMI's stated strategy.

Ü

PBM's reputation for responding quickly to customer needs and developing solutions to industry problems are characteristics that fit well with IMI's operating model.

Ü

PBM enjoys strong distributor and representative relationships - particularly within its main US markets. There are clear opportunities to broaden the market access of both PBM and IMI through their respective routes to market.

Ü

The sharing of best practice between the businesses will facilitate further operational improvement at PBM.

Ü

PBM will be both margin and earnings accretive to IMI.

Ü

The acquisition will deliver a financial return in excess of IMI's cost of capital by the end of year three, before revenue synergies, thereby maintaining the Group's record of strict financial discipline.

 

Commenting on the acquisition, Roy Twite, Chief Executive of IMI, said:"Our strategy at IMI is all about delivering tremendous value by solving industry problems - and putting customers at the heart of our decisions and processes. We are delighted to know that PBM has values and ambitions very similar to our own and I am excited to welcome the company to IMI."Jackie Hu, Divisional Managing Director of IMI Critical Engineering, commented:"I am also thrilled to welcome PBM. The business has fantastic products, a market-leading position and an excellent reputation - particularly in markets that are new to IMI. We are very much looking forward to working with the team and further strengthen and extend our newly combined business."

 

Stuart J. Zarembo, Chairman of the Board and CEO of PBM, added:

"We have built an excellent business at PBM with a great team who are excited about the prospects to develop further as part of a like-minded organisation such as IMI." 

Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Suzanne Bartch / Robert Morgan

Teneo

Tel: +44 (0)203 757 9242

 

 

[1] Exchange rate of £1 = US$1.21 as at close of 15 August 2019 (Source: Bloomberg).

Notes to editors

IMI plc

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, cleanly, efficiently and cost effectively. The Group works with industrial customers across a range of high growth sectors, including energy, transportation and infrastructure, all of which are benefiting from the impact of long-term global trends including climate change, urbanisation, resource scarcity and an ageing population. IMI employs around 11,000 people, has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at: www.imiplc.com.

PBM Inc.

PBM Inc. is a manufacturer of specialty ball valves for sanitary and industrial end-market applications. The Head Office and main manufacturing facility is in Irwin, Pennsylvania, USA and has 104 employees. More information is available at: www.pbmvalve.com.

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQLLFITTRIALIA
Date   Source Headline
4th May 20237:00 amRNSInterim Management Statement
2nd May 20232:46 pmRNSTotal Voting Rights
14th Apr 20233:18 pmRNSDirector/PDMR Shareholding
12th Apr 202311:29 amRNSDirector/PDMR Shareholding
3rd Apr 202311:38 amRNSTotal Voting Rights
29th Mar 20234:53 pmRNSHolding(s) in Company
27th Mar 202311:35 amRNSDirector/PDMR Shareholding
27th Mar 202311:25 amRNSDirector/PDMR Shareholding
24th Mar 20239:49 amRNSAnnual Financial Report
16th Mar 20239:28 amRNSHolding(s) in Company
15th Mar 20232:13 pmRNSDirector/PDMR Shareholding
8th Mar 20233:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPreliminary Results
1st Mar 20231:36 pmRNSTotal Voting Rights
15th Feb 202312:43 pmRNSDirector/PDMR Shareholding
1st Feb 202312:39 pmRNSTotal Voting Rights
26th Jan 202311:00 amRNSHolding(s) in Company
19th Jan 202310:07 amRNSHolding(s) in Company
11th Jan 20232:21 pmRNSDirector/PDMR Shareholding
9th Jan 20233:16 pmRNSHolding(s) in Company
3rd Jan 202310:43 amRNSBlock listing Interim Review
3rd Jan 202310:20 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSCompletion of Heatmiser UK Ltd acquisition
28th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20229:51 amRNSHolding(s) in Company
20th Dec 202210:32 amRNSDirector/PDMR Shareholding
16th Dec 20223:06 pmRNSHolding(s) in Company
16th Dec 20223:02 pmRNSHolding(s) in Company
14th Dec 20224:08 pmRNSDirector/PDMR Shareholding
1st Dec 20223:09 pmRNSTotal Voting Rights
9th Nov 20221:38 pmRNSDirector/PDMR Shareholding
8th Nov 20222:14 pmRNSDirector Declaration
8th Nov 20227:01 amRNSProposed Acquisition of Heatmiser
8th Nov 20227:00 amRNSInterim Management Statement
1st Nov 20223:49 pmRNSTotal Voting Rights
31st Oct 20227:00 amRNSAcquisition of CorSolutions
28th Oct 20222:40 pmRNSHolding(s) in Company
12th Oct 20223:44 pmRNSDirector/PDMR Shareholding
10th Oct 20228:42 amRNSHolding(s) in Company
7th Oct 20229:40 amRNSHolding(s) in Company
3rd Oct 20223:25 pmRNSTotal Voting Rights
14th Sep 20223:45 pmRNSDirector/PDMR Shareholding
1st Sep 202210:36 amRNSTotal Voting Rights
11th Aug 20223:57 pmRNSDirector/PDMR Shareholding
10th Aug 20223:09 pmRNSDirector/PDMR Shareholding
1st Aug 20229:21 amRNSTotal Voting Rights
29th Jul 20227:00 amRNSInterim Results
22nd Jul 202210:29 amRNSHolding(s) in Company
13th Jul 20223:21 pmRNSDirector/PDMR Shareholding
1st Jul 202211:25 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.